These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 818909)

  • 1. ADP-induced inhibition of von Willebrand factor-mediated platelet agglutination.
    Grant RA; Zucker MB; McPherson J
    Am J Physiol; 1976 May; 230(5):1406-10. PubMed ID: 818909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets have more than one binding site for von Willebrand factor.
    Ruggeri ZM; De Marco L; Gatti L; Bader R; Montgomery RR
    J Clin Invest; 1983 Jul; 72(1):1-12. PubMed ID: 6223940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of von Willebrand factor-platelet interaction by fibrinogen.
    Piétu G; Cherel G; Marguerie G; Meyer D
    Nature; 1984 Apr 12-18; 308(5960):648-9. PubMed ID: 6324004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique interactions of asialo von Willebrand factor with platelets in platelet-type von Willebrand disease.
    Miller JL; Ruggeri ZM; Lyle VA
    Blood; 1987 Dec; 70(6):1804-9. PubMed ID: 3118988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of agonists and antagonists of platelet aggregation on von Willebrand factor-mediated platelet agglutination.
    McPherson J; Zucker MB; Mauss EA; Brownlea S
    Thromb Haemost; 1991 May; 65(5):573-7. PubMed ID: 1871718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP.
    Adelman B; Carlson P; Powers P
    Blood; 1987 Nov; 70(5):1362-6. PubMed ID: 2822171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.